A new lawsuit accuses more than two dozen popular wine producers in California of selling wine containing high levels of arsenic.
Tests by three independent laboratories found that in some cases arsenic levels were 500 percent higher than what’s considered safe for drinking water.
Chairman of the Department of Urology and Chief of Robotic Surgery at Lenox Hill Hospital Dr. David Samadi appeared on "America's News Headquarters" today to weigh in on if these wines should be considered dangerous.
Dr. Samadi explained that we don't know how hazardous to one's health these wines might be because as of now there is no good standard acceptable arsenic levels in wine.
"Unless you're drinking a bottle of red wine every day, this is not really, in my opinion, going to affect you," Dr. Samadi said. "So I would not really panic."
He added that this is a bigger problem in cheap wines, so he recommended that you buy higher quality bottles if you plan on drinking wine. You can find the list of all the wines listed in the lawsuit on SamadiMD.com.
Dr. Samadi also weighed in on a new study that found that a urine test may help detect kidney cancer early, which he said could be very significant.
62,000 people are diagnosed with kidney cancer each year in the U.S., and 14,000 people die of the disease yearly, according to the American Cancer Society.
"Instead of CAT scans and MRIs, which [are] used to diagnose kidney cancer, if we have a magic urine test - which in this particular case, you give a urine specimen, they look for two proteins, and with 95 percent accuracy they can say whether you have kidney cancer or not - this is a game-changer," Dr. Samadi said.
He added that we need more studies and longer periods of study, but this will be very significant as doctors and researchers come up with better screening tests.
"Screening helps and can save lives, so I think this is very exciting."
See more from Dr. Samadi: